Chargement en cours...
New Schizophrenia Treatments Address Unmet Clinical Needs
We present several novel drugs in development for enhancing cognition, treating negative symptoms, and providing improved options for treatment-resistant patients. Drug makers aim to enhance safety profiles and increase patient compliance to therapy.
Enregistré dans:
| Publié dans: | P T |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MediMedia USA, Inc.
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5265239/ https://ncbi.nlm.nih.gov/pubmed/28163559 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|